EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients

Wei-Chen Lee, Hao-Chien Hung iD, Jin-Chiao Lee iD, Chung-Guei Huang iD, Po-Wei Huang, Po-Wen Gu, Yu-Chao Wang, Chih-Hsien Cheng, Tsung-Han Wu iD, Chen-Fang Lee, Ting-Jung Wu iD, Hong-Shiue Chou iD und 1 weitere

Viruses · 2023

DOI: 10.3390/v15030678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Wei-Chen Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Taoyuan 33357, Taiwan. Hauptthemen laut MEDLINE: Liver Transplantation, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang-Gung Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplant recipients are immunocompromised and have low immunogenicity to produce antibodies in anti-COVID-19 vaccination. Whether immunosuppressant adjustment could facilitate anti-COVID-19 antibody production in anti-COVID-19 mRNA vaccination is undetermined. Our patients were informed to temporarily suspend mycophenolate mofetil (MMF) or everolimus (EVR) for 2 weeks during both the 1st and 2nd doses of Moderna mRNA-1273 vaccine. A total of 183 recipients receiving two doses of Moderna mRNA-1273 vaccine were enrolled and grouped into tacrolimus monotherapy (MT, n = 41), and dual therapy with non-adjustment (NA, n = 23), single suspension (SS, n = 19) and double suspension (DS, n = 100) of MMF/EVR in two-dose mRNA vaccination. A total of 155 (84.7%) patients had a humoral response to vaccines in this study. The humoral response rates were 60.9%, 89.5%, 91.0% and 80.5% in NA, SS, DS, and MT group patients, respectively (p = 0.003). Multivariate analysis showed that favorable factors for humoral response were temporary suspension of MMF/EVR and monotherapy, and unfavorable factors were deceased donor liver transplantation, WBC count < 4000/uL, lymphocyte < 20% and tacrolimus trough level ≥ 6.8 ng/mL. In conclusion, temporary two-week suspension of anti-proliferation immunosuppressants could create a window to facilitate antibody production during anti-COVID-19 mRNA vaccination. This concept may be applied to other vaccinations in liver transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCOVID-19HumansImmunosuppressive Agents2019-nCoV Vaccine mRNA-1273TacrolimusAntibody FormationLiving DonorsVaccinationEverolimusMycophenolic AcidRNA, MessengerTransplant RecipientsAntibodies, Viral

Stichwörter der Autor:innen

COVID-19Moderna mRNA-1273 vaccineimmunosuppressantliver transplantationvaccine

Substanzen

Immunosuppressive Agents2019-nCoV Vaccine mRNA-1273TacrolimusEverolimusMycophenolic AcidRNA, MessengerAntibodies, Viral

Autor:innen und Institutionen

  • Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Taoyuan 33357, Taiwan.
  • Surgery, College of Medicine, Chang-Gung University, Taoyuan 33357, Taiwan.
  • Department of Laboratory Medicine, Chang-Gung Memorial Hospital, Taoyuan 33357, Taiwan.
  • Department of Medical Biotechnology and Laboratory Science, Chang-Gung University College of Medicine, Taoyuan 33357, Taiwan.

ORCID-Profile: Hao-Chien Hung, Jin-Chiao Lee, Chung-Guei Huang, Tsung-Han Wu, Ting-Jung Wu, Hong-Shiue Chou

Förderung

  • Chang-Gung Medical Foundation

Zitieren

APA

Lee, W. C., Hung, H. C., Lee, J. C., Huang, C. G., Huang, P. W., Gu, P. W., Wang, Y. C., Cheng, C. H., Wu, T. H., Lee, C. F., Wu, T. J., Chou, H. S., & Chan, K. M. (2023). Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients. Viruses. https://doi.org/10.3390/v15030678

Vancouver

Lee WC, Hung HC, Lee JC, Huang CG, Huang PW, Gu PW, et al. Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients. Viruses. 2023. doi:10.3390/v15030678

BibTeX
@article{Lee2023,
  author = {Lee, Wei-Chen and Hung, Hao-Chien and Lee, Jin-Chiao and Huang, Chung-Guei and Huang, Po-Wei and Gu, Po-Wen and Wang, Yu-Chao and Cheng, Chih-Hsien and Wu, Tsung-Han and Lee, Chen-Fang and Wu, Ting-Jung and Chou, Hong-Shiue and Chan, Kun-Ming},
  title = {Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15030678}
}
Kostenlos starten →